financetom
Business
financetom
/
Business
/
Royal Caribbean Signs Deal for Shipbuilding Slots at Finnish Shipyard Through 2036
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Royal Caribbean Signs Deal for Shipbuilding Slots at Finnish Shipyard Through 2036
Sep 23, 2025 6:18 AM

08:37 AM EDT, 09/23/2025 (MT Newswires) -- Royal Caribbean (RCL) said Tuesday that it has signed an agreement that secures its rights to build at the Meyer Turku shipyard in Finland until 2036.

Royal Caribbean said that as of Tuesday, Meyer Turku has built and has launched two Icon Class ships, with a third one scheduled for the summer of 2026 and Icon 4 scheduled to be delivered in 2027, the company said.

Meyer Turku and Royal Caribbean, along with other partners, plan to build more Icon Class ships in the next decade, Casimir Lindholm, the shipyard's chief executive officer, said.

Royal Caribbean said that orders beyond Icon 5 are subject to the exercise of options and execution of firm construction agreements.

Shares of the company were up 1.1% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CENCOSUD S.A. ANNOUNCES TENDER RESULTS AND EXPIRATION TIME OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 4.375% NOTES DUE 2027 (CUSIP Nos. 15132H AH4; P2205J AQ3 / ISIN Nos. US15132HAH49; US
CENCOSUD S.A. ANNOUNCES TENDER RESULTS AND EXPIRATION TIME OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 4.375% NOTES DUE 2027 (CUSIP Nos. 15132H AH4; P2205J AQ3 / ISIN Nos. US15132HAH49; US
Apr 13, 2026
SANTIAGO, Chile, April 13, 2026 /PRNewswire/ -- Cencosud S.A. (the Company) today announced the tender results in connection with its offer to purchase for cash any and all of its outstanding 4.375% Notes due 2027 (the Notes) (the Offer). The Offer was made upon the terms and subject to the conditions (including the Financing Condition (as defined in the Offer...
Volato Group and M2i Global Target Late-May Close for Proposed Critical Minerals Merger After Form S-4 Declared Effective
Volato Group and M2i Global Target Late-May Close for Proposed Critical Minerals Merger After Form S-4 Declared Effective
Apr 13, 2026
Regulatory Milestone Clears Path to Shareholder Vote and Transaction Completion. ATLANTA & RENO, Nev.--(BUSINESS WIRE)-- Volato Group, Inc. ( SOAR ) (the “Company” or “Volato”) and M2i Global, Inc. ( MTWO ) (“M2i Global”) today announced that the U.S. Securities and Exchange Commission has declared effective the Registration Statement on Form S-4 relating to Volato’s proposed merger with M2i Global...
Spyre Therapeutics' SPY001 to Treat Ulcerative Colitis Meets Phase 2 Trial Endpoints; Shares Surge Pre-Bell
Spyre Therapeutics' SPY001 to Treat Ulcerative Colitis Meets Phase 2 Trial Endpoints; Shares Surge Pre-Bell
Apr 13, 2026
07:59 AM EDT, 04/13/2026 (MT Newswires) -- Spyre Therapeutics ( SYRE ) said Monday that its SPY001 investigational treatment for moderate-to-severely active ulcerative colitis met its primary, and key secondary endpoints in a phase 2 trial. The biotech firm said SPY001 was generally well tolerated by patients in the study, with no major safety concerns reported so far. Spyre also...
ALT5 Sigma Corporation Reports Full Year 2025 Financial Results
ALT5 Sigma Corporation Reports Full Year 2025 Financial Results
Apr 13, 2026
ALT5's core fintech platform continued to scale in 2025, supported by growth across payments, trading, and settlement processing of approximately $3.5 billion in transaction volume during the year ALT5 strengthened its operating foundation through compliance restoration, governance upgrades, and continued platform expansion following the acquisition of Mswipe Recent initiatives demonstrate the Company's strategy to extend its core institutional infrastructure into...
Copyright 2023-2026 - www.financetom.com All Rights Reserved